secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001140361-25-023648
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Nirav Jhaveri departs Opus Genetics; Amy Rabourn appointed interim principal financial officer
--------------------------------------------------------------------------------

- CFO Nirav Jhaveri terminated without cause on June 25, 2025; no disagreement with auditors or management.
- Jhaveri eligible for severance per employment agreement subject to separation release.
- Amy Rabourn, SVP of Finance, serves as principal financial and accounting officer until successor appointed.
- Rabourn has 20+ years finance experience, CPA, previously at Gemphire and Pfizer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125023648/0001140361-25-023648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125023648/ef20051087_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-023648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer